Richard Haubrich

Statistics

Publications

136

Citations

12.1K

H-Index

Active since

1984

Affiliations

University of California San Diego(Current)

Harvard University

Gilead Sciences (United States)

Cornell University

Harbor–UCLA Medical Center

Richard Haubrich is an author at University of California San Diego specializing in antiretroviral therapy, antiviral therapy, and infectious diseases.

ORCID

Publications per year

1984–2024

136

Publications

136

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Scott M. Hammer, David Katzenstein, Michael D. Hughes et al. · New England Journal of Medicine · 1996 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

Sharon A. Riddler, Richard Haubrich, A. Gregory DiRienzo et al. · New England Journal of Medicine · 2008 · 675 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

Richard Haubrich, Susan J. Little, Judith S. Currier et al. · AIDS · 1999 · 551 citations

Public Health, Infectious Disease Control, Hiv Control +16

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

José Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn et al. · The Lancet · 2007 · 516 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Bonaventura Clotet, Nicholas Bellos, Jean‐Michel Molina et al. · The Lancet · 2007 · 480 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11

1–5 of 136